Thursday, June 27, 2013

ScripsAmerica, Inc. (SCRC) Inks Strategic Representation Agreement with DPG Distribution for Launch of RapiMed®

ScripsAmerica, a supplier of pharmaceutical products to a wide range of end users across the health care industry, has entered into a two-year agreement with DPG Distribution (DPG) for the exclusive right to purchase, promote, and resell its RapiMed® over-the-counter products throughout North America, initially starting with its children’s pain reliever and fever reducer.

DPG Distribution offers on a global scale the sales, marketing, and distribution services of targeting high-end retail consumer products. The company calls on some of the largest retail chains in the world such as Wal-Mart, Costco, Target, Walgreens, CVS, and ShopRite. The agreement contains a provision whereby its exclusivity is contingent upon DPG meeting designated sales quotas for RapiMed®.

“ScripsAmerica is extremely proud and pleased to announce this agreement, which we believe has tremendous growth implications for our company and its shareholders,” ScripsAmerica’s CEO, Bob Schneiderman, stated in the press release. “DPG Distribution’s network of clients is not only tremendous in size and quality, but it contains some of the world’s largest retailers who are at the pinnacle of our target market.”

The agreement is expected to maximize ScripsAmerica’s national market opportunities for RapiMed® Children’s Pain Reliever and Fever Reducer, which the company anticipates launching in September.

“We expect this development to have a profound and positive impact on the success of RapiMed®’s product launch as well as its ongoing sales and market penetration,” continued Schneiderman.

Gordon Jones, chief operating officer of DPG Distribution, added, “DPG is very excited to represent RapiMed® in the North American market. RapiMed® has the potential to experience great success penetrating the massive market for children’s pain relievers because of its speed, effectiveness, dosing accuracy and safety. Currently, we believe a very large opportunity exists for a new, superior product like RapiMed® to be introduced and capture significant market share. DPG looks forward to a long and profitable partnership with ScripsAmerica.”

For more information, visit www.ScripsAmerica.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: